| Ytd | -35.73% | |
| 1y | -86.51% |
| Open | 0.45 | Prev Close | 0.45 | Low | 0.43 | High | 0.47 | Mkt Cap | 6.72M |
| Vol | 159.37K | Avg Vol | 337.49K | EPS | -4.01 | P/E | N/A | Forward P/E | -0.98 |
| Beta | -0.18 | Short Ratio | 1.62 | Inst. Own | 36.40% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 0.46 | 200-d Avg | 1.14 | 1yr Est | 2.50 |
XAIR News
Beyond Air, Inc. (XAIR) Q4 2026 Earnings Call Transcript
U.S. stock futures slipped on Friday after a mixed close on Thursday.
On Friday, Beyond Air (NASDAQ:XAIR) discussed fourth-quarter financial results during its earnings c
Companies Reporting Before The Bell • Beyond Air (NASDAQ:XAIR) is estimated to report quarterly loss
Beyond Air (NASDAQ:XAIR) reported quarterly losses of $(0.77) per share which missed the analyst con
Revenue increased by 107% year-over-year to $7.7 million in the full fiscal year 2026; increased rev
The CNN Fear & Greed Index, measuring market sentiment, showed a slight decline on Thursday, rem
U.S. stock futures are down, but some stocks to watch today include Apogee, BitGo, Cineverse, Synapt
Beyond Air, Inc. (NASDAQ:XAIR), a commercial-stage medical device and biopharmaceutical company focu